Skip to main navigation
About
Overview
Values
Management
Board of Directors
Science
Atacicept
IgAN
LN
MAU868
Publications
Patients
Careers
Investors
Overview
Stock Information
News & Events
Presentations
Financial Information
Analyst Coverage
Corporate Governance
Investor Resources
Contact
About
Overview
Values
Management
Board of Directors
Science
Atacicept
IgAN
LN
MAU868
Publications
Patients
Careers
Investors
Overview
Stock Information
News & Events
Presentations
Financial Information
Analyst Coverage
Corporate Governance
Investor Resources
Contact
Event Details
January 4, 2023 at 8:00 AM EST
ORIGIN Phase 2b Clinical Trial Week 24 Results
Listen to webcast
Top
